Industry Discovery & Development Partnership Program
Industry Discovery & Development Partnership Program supports companies developing therapeutics and devices through research and clinical trials to advance products that cure, treat, or prevent type 1 diabetes.
Browse similar grants
Funder: Breakthrough T1D
Due Dates: Rolling (Invited LOIs and applications) | Year-round (Company inquiries)
Funding Amounts: Annual budget as approved; award duration open
Summary: Supports industry-led discovery, development, and commercialization of therapeutics and devices to cure, treat, or prevent type 1 diabetes.
Key Information: Companies must commit matching funds at least equal to the requested award throughout the funding period.
Description
Breakthrough T1D’s Industry Discovery & Development Partnership (IDDP) program supports for-profit companies conducting research closely aligned with its type 1 diabetes (T1D) research strategy. It combines industry’s product-development capabilities with Breakthrough T1D’s research and patient-advocacy expertise to accelerate therapeutics and devices toward commercialization and foster long-term collaboration with the T1D community.
Supported work includes translational research, clinical trials, and device development with a clear pathway toward regulatory approval and commercialization. Priority areas include cardiovascular disease in T1D, the clinical impact of insulin dosing, ketones and continuous ketone monitoring, and continuous glucose monitoring–insulin pump integration. Projects should address unmet clinical needs and demonstrate commercial potential. Funding is intended to help companies reach a defined inflection point in discovery, development, or regulatory approval.
